"Designing Growth Strategies is in our DNA"

Asia Pacific Insulin Pump Market Size, Share & COVID-19 Impact Analysis, By Product Type (Pumps [Tethered Pumps, Patch Pumps, and Others] and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107537

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Ageing Population, Prevalence and Cost Burden of Diabetes, Key Countries, 2022
    2. Evolution of Insulin Pumps
    3. Reimbursement Scenario, in Key Countries
    4. Impact of COVID-19 on the Market
    5. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
  5. Asia Pacific Insulin Pumps Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Pumps
        1. Tethered Pumps
        2. Patch Pumps
        3. Others
      2. Consumables
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Type 1 Diabetes
      2. Type 2 Diabetes
    3. Market Analysis, Insights and Forecast – By Distribution channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Disease Indication
      2. China
        1. By Disease Indication
      3. India
        1. By Disease Indication
      4. Australia
        1. By Disease Indication
      5. Southeast Asia
        1. By Disease Indication
      6. Rest of Asia Pacific
        1. By Disease Indication
  6. Competitive Analysis
    1. Asia Pacific Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Medtronic
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Insulet Corporation
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Ypsomed AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Tandem Diabetes Care
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Terumo Corporation
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. MicroTech Medical, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. EOFLOW CO., LTD.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. SOOIL Developments Co., Ltd
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Ageing Population, Prevalence and Cost Burden of Diabetes, Key Countries, 2022
    2. Evolution of Insulin Pumps
    3. Reimbursement Scenario, in Key Countries
    4. Impact of COVID-19 on the Market
    5. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
  5. Asia Pacific Insulin Pumps Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Pumps
        1. Tethered Pumps
        2. Patch Pumps
        3. Others
      2. Consumables
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Type 1 Diabetes
      2. Type 2 Diabetes
    3. Market Analysis, Insights and Forecast – By Distribution channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Disease Indication
      2. China
        1. By Disease Indication
      3. India
        1. By Disease Indication
      4. Australia
        1. By Disease Indication
      5. Southeast Asia
        1. By Disease Indication
      6. Rest of Asia Pacific
        1. By Disease Indication
  6. Competitive Analysis
    1. Asia Pacific Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Medtronic
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Insulet Corporation
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Ypsomed AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Tandem Diabetes Care
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Terumo Corporation
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. MicroTech Medical, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. EOFLOW CO., LTD.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. SOOIL Developments Co., Ltd
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Asia Pacific Insulin Pumps Market Value Share (%), by Product Type, 2022 & 2030

Figure 2:  Asia Pacific Insulin Pumps Market Value Share (%), by Disease Indication, 2022 & 2030

Figure 3:  Asia Pacific Insulin Pumps Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 4:  Asia Pacific Insulin Pumps Market Value (USD billion), by Country/Sub-region, 2022 & 2030

Figure 5:  Asia Pacific Insulin Pumps Market Share (%), By Company, 2022

Table 1:  Asia Pacific Insulin Pumps Market Revenue (USD billion) Forecast, by Product Type, 2019-2030

Table 2:  Asia Pacific Insulin Pumps Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030

Table 3:  Asia Pacific Insulin Pumps Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 4:  Asia Pacific Insulin Pumps Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 5:  China Insulin Pumps Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030

Table 6:  Japan Insulin Pumps Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030

Table 7:  India Insulin Pumps Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030

Table 8:  Australia Insulin Pumps Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030

Table 9:  Southeast Asia Insulin Pumps Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030

Table 10:  Rest of Asia Pacific Insulin Pumps Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030

  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann